The impact of statins on the metabolism of patients with cardiovascular disease

dc.contributor.author	Cojocari, Felicia
dc.date.accessioned	2020-07-06T10:51:44Z
dc.date.available	2020-07-06T10:51:44Z
dc.date.issued	2018
dc.identifier.citation	COJOCARI, Felicia. The impact of statins on the metabolism of patients with cardiovascular disease. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 45-46.	en_US
dc.identifier.uri	https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf
dc.identifier.uri	https://repository.usmf.md/handle/20.500.12710/10995
dc.description	Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova	en_US
dc.description.abstract	Introduction. Statins are a class of lipid-lowering medications, also known as HMG-CoA reductase inhibitors. They are considered one of the most popular prescribed agents worldwide for treatment of hypercholesterolemia. Statins are effective drugs to reduce cardiovascular events and mortality secondary to dyslipidemia. Statin therapy is considered as the standard dyslipidemia therapy. Except lipid-lowering effect, it is known that statins have cholesterolindependent effects (pleiotropic effects).	en_US
dc.language.iso	en	en_US
dc.publisher	MedEspera	en_US
dc.subject	statins	en_US
dc.subject	pleiotropic effects	en_US
dc.subject	cardiovascular diseases	en_US
dc.title	The impact of statins on the metabolism of patients with cardiovascular disease	en_US
dc.type	Article	en_US